Featured projects

Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs - FIBROTARGET

Principal investigator: Maria Azucena Salas Martinez.
Funder: Institut d'Investigacions Biomèdiques August Pi i Sunyer (Entidad de origen); European Commission .

Code: 101080523.

Duration: 01/04/2023 - 01/03/2028
Estudio de la heterogeneidad en la enfermedad inflamatoria Intestinal mediante el uso de análisis de célula única

Principal investigator: Maria Azucena Salas Martinez.
Funder: Ministerio de Ciencia e Innovación .

Code: PID2021-123918OB-I00.

Duration: 01/09/2022 - 01/09/2025
Early detection of perianal fistulizing disease - Pathophysiology and Imaging

Principal investigator: Julian Panes Diaz, Maria Azucena Salas Martinez.
Funder: The Leona M. & Harry B. Helmsley Charity Trust .

Code: 2008-04050.

Duration: 01/11/2019 - 01/11/2022
Taxonomy, Treatment, Targets and Remission (3TR): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Principal investigator: Juan de Dios Canete Crespillo, Maria Azucena Salas Martinez, Luis F Quintana Porras, Ricard Cervera Segura, Yolanda Blanco Morgado.
Funder: European Commission .

Code: CE_IMI2-2018-14.

Duration: 01/09/2019 - 31/08/2026
Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

Principal investigator: Maria Azucena Salas Martinez, Julian Panes Diaz.
Funder: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo).

Code: RTI2018-096946-B-I00.

Duration: 01/01/2019 - 31/12/2021
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3

Principal investigator: Maria Azucena Salas Martinez.
Funder: European Commission (Programa Horizon 2020). (Promotor).

Code: H2020-NMBP-2016-2017.

Duration: 02/01/2017 - 31/12/2020
Trasplante autólogo de células madre hematopoyéticas en la enfermedad de Crohn: factores moleculares, inmunes y microbiológicos implicados en el control de la enfermedad

Principal investigator: Maria Azucena Salas Martinez.
Funder: Ministerio de Economía e Innovación. Comisión Interministerial de Ciencia y Tecnología. Secretaría General del Plan Nacional de I+D (Promotor).

Code: I+D SAF2015-66379.

Duration: 01/01/2016 - 31/12/2018

The research of this group can be carried out thanks to the funders.

Donations that make possible the research of this group.

Featured projects

Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs - FIBROTARGET

Estudio de la heterogeneidad en la enfermedad inflamatoria Intestinal mediante el uso de análisis de célula única

Early detection of perianal fistulizing disease - Pathophysiology and Imaging

Taxonomy, Treatment, Targets and Remission (3TR): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)

New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3

Trasplante autólogo de células madre hematopoyéticas en la enfermedad de Crohn: factores moleculares, inmunes y microbiológicos implicados en el control de la enfermedad

Major founders

Contributors